Net Cash Provided by (Used in) Financing Activities of Core Scientific, Inc./tx from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Core Scientific, Inc./tx annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Core Scientific, Inc./tx Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $4,198,000, a 108% decline year-over-year.
  • Core Scientific, Inc./tx annual Net Cash Provided by (Used in) Financing Activities for 2025 was $63,102,000, a 108% decline from 2024.
  • Core Scientific, Inc./tx annual Net Cash Provided by (Used in) Financing Activities for 2024 was $819,567,000.
  • Core Scientific, Inc./tx annual Net Cash Provided by (Used in) Financing Activities for 2023 was $44,649,000, a 115% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Core Scientific, Inc./tx Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $63,102,000 -$882,669,000 -108% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $819,567,000 +$864,216,000 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 $44,649,000 -$350,802,000 -115% 01 Jan 2023 31 Dec 2023 10-K 02 Mar 2026 2025 FY
2022 $306,153,000 -$297,379,000 -49% 01 Jan 2022 31 Dec 2022 10-K/A 02 Mar 2026 2024 FY
2021 $603,532,000 +$562,809,000 +1382% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2020 $40,723,000 01 Jan 2020 31 Dec 2020 10-K 04 Apr 2023 2022 FY

Core Scientific, Inc./tx Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,198,000 -$58,561,000 -108% 01 Jan 2025 31 Mar 2025 10-Q/A 02 Mar 2026 2025 Q1
Q1 2024 $54,363,000 +$55,384,000 01 Jan 2024 31 Mar 2024 10-Q/A 02 Mar 2026 2025 Q1
Q1 2023 $1,021,000 -$252,486,000 -100% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $45,100,000 01 Jul 2022 30 Sep 2022 10-Q 22 Nov 2022 2022 Q3
Q1 2022 $251,465,000 +$230,432,000 +1096% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $21,033,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.